Volitionrx (VNRX) Gross Profit (2019 - 2025)
Volitionrx filings provide 7 years of Gross Profit readings, the most recent being -$1.0 million for Q4 2025.
- On a quarterly basis, Gross Profit rose 21.95% to -$1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.7 million, a 38.26% increase, with the full-year FY2025 number at -$2.6 million, up 39.33% from a year prior.
- Gross Profit hit -$1.0 million in Q4 2025 for Volitionrx, down from -$420186.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of -$401871.0 in Q1 2021 to a low of -$1.8 million in Q4 2021.
- Median Gross Profit over the past 5 years was -$1.3 million (2023), compared with a mean of -$1.2 million.
- Biggest five-year swings in Gross Profit: crashed 443.25% in 2021 and later skyrocketed 55.31% in 2025.
- Volitionrx's Gross Profit stood at -$1.8 million in 2021, then rose by 13.56% to -$1.6 million in 2022, then decreased by 6.19% to -$1.7 million in 2023, then rose by 22.16% to -$1.3 million in 2024, then increased by 21.95% to -$1.0 million in 2025.
- The last three reported values for Gross Profit were -$1.0 million (Q4 2025), -$420186.0 (Q3 2025), and -$636846.0 (Q2 2025) per Business Quant data.